UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG

Annals of oncology, 2006-04, Vol.17 (4), p.563-570

2006

Volltextzugriff (PDF)

Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis

British journal of dermatology (1951), 2005-03, Vol.152 (3), p.531-536

2005

Volltextzugriff (PDF)

Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paper

The Journal of dermatological treatment, 2015-04, Vol.26 (2), p.103-112

2015

Volltextzugriff (PDF)

Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial

British journal of dermatology (1951), 2006-06, Vol.154 (6), p.1161-1168

2006

Volltextzugriff (PDF)

Regression of melanoma metastases following treatment with the n-bisphosphonate zoledronate and localised radiotherapy

Clinical immunology (Orlando, Fla.), 2009-06, Vol.131 (3), p.367-373

2009

Volltextzugriff (PDF)

Dendritic cell vaccination for cancer therapy

Oncogene, 2000-12, Vol.19 (56), p.6673-6679

Nestle, F O

2000

Volltextzugriff (PDF)

Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets

The Journal of immunology (1950), 1993-12, Vol.151 (11), p.6535-6545

1993

Volltextzugriff (PDF)

Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells

The American journal of pathology, 1997-02, Vol.150 (2), p.641-651

1997

Volltextzugriff (PDF)

Activation of dendritic antigen-presenting cells expressing common heat shock protein receptor CD91 during induction of psoriasis

British journal of dermatology (1951), 2005-06, Vol.152 (6), p.1211-1218

2005

Volltextzugriff (PDF)

Clinical relevance of immunogenicity of biologics in psoriasis: Implications for treatment strategies

Journal of the European Academy of Dermatology and Venereology, 2014-11, Vol.28 (11), p.1424-1430

2014

Volltextzugriff (PDF)

Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis

Human genetics, 2007-09, Vol.122 (2), p.201-206

2007

Volltextzugriff (PDF)

An immunologically relevant rodent model demonstrates safety of therapy using a tumour‐specific IgE

Allergy (Copenhagen), 2018-12, Vol.73 (12), p.2328-2341

2018

Volltextzugriff (PDF)

Skin resident memory CD8+ T cells are phenotypically and functionally distinct from circulating populations and lack immediate cytotoxic function

Clinical and experimental immunology, 2018-10, Vol.194 (1), p.79-92

2018

Volltextzugriff (PDF)

Generalised pustular psoriasis induced by cyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept

Dermatology (Basel), 2002-01, Vol.205 (2), p.213-216

2002

Volltextzugriff (PDF)

Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha

The Journal of experimental medicine, 2004-03, Vol.199 (5), p.731-736

2004

Volltextzugriff (PDF)

Interferon-α and viral triggers promote functional maturation of human monocyte-derived dendritic cells

British journal of dermatology (1951), 2008-05, Vol.158 (5), p.921-929

2008

Volltextzugriff (PDF)

Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity

Clinical and experimental allergy, 2011-10, Vol.41 (10), p.1400-1413

2011

Volltextzugriff (PDF)

Human Dermal Dendritic Cells Process and Present Soluble Protein Antigens

Journal of investigative dermatology, 1998-05, Vol.110 (5), p.762-766

1998

Volltextzugriff (PDF)

MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution

The American journal of pathology, 1997-12, Vol.151 (6), p.1549-1553

1997

Volltextzugriff (PDF)

Treatment of verrucous carcinoma with imiquimod and CO2 laser ablation

Dermatology (Basel), 2003-01, Vol.207 (1), p.119-122

2003

Volltextzugriff (PDF)

Dendritic cells: On the move from bench to bedside

Nature medicine, 2001-07, Vol.7 (7), p.761-765

2001

Volltextzugriff (PDF)

Progress in Understanding the Immunopathogenesis of Psoriasis

Actas dermo-sifiliograficas, 2009-12, Vol.100 (Suppl 2), p.2-13

2009

Volltextzugriff (PDF)

Sézary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-γ receptor β-chain)

Blood, 1996-08, Vol.88 (4), p.1383-1389

1996

Volltextzugriff (PDF)

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

Nature medicine, 1998-03, Vol.4 (3), p.328-332

1998

Volltextzugriff (PDF)

Vaccines and melanoma

Clinical and experimental dermatology, 2002-10, Vol.27 (7), p.597-601

Nestle, F. O.

2002

Volltextzugriff (PDF)

1 – 25 von 217

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(196)
Mit Volltextzugriff
(157)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG

Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis

Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paper

Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial

Regression of melanoma metastases following treatment with the n-bisphosphonate zoledronate and localised radiotherapy

Dendritic cell vaccination for cancer therapy

Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets

Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells

Activation of dendritic antigen-presenting cells expressing common heat shock protein receptor CD91 during induction of psoriasis

Clinical relevance of immunogenicity of biologics in psoriasis: Implications for treatment strategies

Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis

An immunologically relevant rodent model demonstrates safety of therapy using a tumour‐specific IgE

Skin resident memory CD8+ T cells are phenotypically and functionally distinct from circulating populations and lack immediate cytotoxic function

Generalised pustular psoriasis induced by cyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept

Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha

Interferon-α and viral triggers promote functional maturation of human monocyte-derived dendritic cells

Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity

Human Dermal Dendritic Cells Process and Present Soluble Protein Antigens

MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution

Treatment of verrucous carcinoma with imiquimod and CO2 laser ablation

Dendritic cells: On the move from bench to bedside

Progress in Understanding the Immunopathogenesis of Psoriasis

Sézary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-γ receptor β-chain)

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

Vaccines and melanoma

Suchergebnisse filtern